Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Anesth Analg. 2009 Jan;108(1):345–350. doi: 10.1213/ane.0b013e31818c7da5

Table 4.

Secondary Endpoints

Group 0.2%
(n = 23)
Group 0.4%
(n = 27)
Home oral opioid
   consumption (mg)*
  Postoperative day 1 10 (0–20) 20 (10–30)
  Postoperative day 2 10 (5–20) 15 (5–30)
  Postoperative day 3 15 (5–30) 15 (5–25)
Awakenings because of
   pain (#)
  Postoperative day/night 0 0 (0–2) 2 (0–4)
  Postoperative day/night 1 0 (0–1) 0 (0–3)
  Postoperative day/night 2 0 (0–2) 0 (0–1)

Values are reported as median (25th–75th percentiles).

*

Oral opioid provided as 5 mg oxycodone tablets. Values include home opioid consumption in the 24-h previous to the daily data-collection phone calls.

Because each comparison dilutes all other P-values, we restricted our analysis to four comparisons among secondary end points. For this reason, no statistical comparisons were applied to the data of this table.